Moreover, we verified through experiments that EH inhibits the PI3K-AKT signaling pathway through its active ingredients, quercetin, and wedelolactone, thereby inhibiting the proliferation of HCC cells and promoting apoptosis of HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.